DNA vaccines - PubMed (original) (raw)

Review

DNA vaccines

J B Ulmer et al. Curr Opin Immunol. 1996 Aug.

Abstract

Preclinical DNA vaccine development has continued apace during the past year, with the investigation of several new infectious and non-infectious disease targets as well as advances in our understanding of some of the basic immunologic mechanisms, such as effector cells, responsible for conferring protection. The coming year promises to be at least as exciting, as initial human clinical studies have begun.

PubMed Disclaimer

Similar articles

• Toward the development of DNA vaccines.
  Ulmer JB, Donnelly JJ, Liu MA. Ulmer JB, et al. Curr Opin Biotechnol. 1996 Dec;7(6):653-8. doi: 10.1016/s0958-1669(96)80078-4. Curr Opin Biotechnol. 1996. PMID: 8939639 Review.
• Immunologic basis of vaccine vectors.
  Liu MA. Liu MA. Immunity. 2010 Oct 29;33(4):504-15. doi: 10.1016/j.immuni.2010.10.004. Immunity. 2010. PMID: 21029961 Review.
• Vaccine technologies: view to the future.
  Rabinovich NR, McInnes P, Klein DL, Hall BF. Rabinovich NR, et al. Science. 1994 Sep 2;265(5177):1401-4. doi: 10.1126/science.7521064. Science. 1994. PMID: 7521064 Review.
• An mRNA Vaccine Encoding Rabies Virus Glycoprotein Induces Protection against Lethal Infection in Mice and Correlates of Protection in Adult and Newborn Pigs.
  Schnee M, Vogel AB, Voss D, Petsch B, Baumhof P, Kramps T, Stitz L. Schnee M, et al. PLoS Negl Trop Dis. 2016 Jun 23;10(6):e0004746. doi: 10.1371/journal.pntd.0004746. eCollection 2016 Jun. PLoS Negl Trop Dis. 2016. PMID: 27336830 Free PMC article.
• Preclinical testing of new vaccines for tuberculosis: a comprehensive review.
  Orme IM. Orme IM. Vaccine. 2006 Jan 9;24(1):2-19. doi: 10.1016/j.vaccine.2005.07.078. Epub 2005 Aug 8. Vaccine. 2006. PMID: 16139397 Review.

Cited by

• AMDV Vaccine: Challenges and Perspectives.
  Markarian NM, Abrahamyan L. Markarian NM, et al. Viruses. 2021 Sep 14;13(9):1833. doi: 10.3390/v13091833. Viruses. 2021. PMID: 34578415 Free PMC article. Review.
• Comparison of Neutralizing Dengue Virus B Cell Epitopes and Protective T Cell Epitopes With Those in Three Main Dengue Virus Vaccines.
  Pinheiro JR, Camilo Dos Reis E, Souza RDSO, Rocha ALS, Suesdek L, Azevedo V, Tiwari S, Rocha BGS, Birbrair A, Méndez EC, Luiz WB, Amorim JH. Pinheiro JR, et al. Front Immunol. 2021 Aug 20;12:715136. doi: 10.3389/fimmu.2021.715136. eCollection 2021. Front Immunol. 2021. PMID: 34489965 Free PMC article.
• Multi-walled carbon nanotubes increase antibody-producing B cells in mice immunized with a tetravalent vaccine candidate for dengue virus.
  Calegari LP, Dias RS, de Oliveira MD, Pessoa CR, de Oliveira AS, Oliveira AF, da Silva CC, Fonseca FG, Versiani AF, De Paula SO. Calegari LP, et al. J Nanobiotechnology. 2016 Jul 27;14(1):61. doi: 10.1186/s12951-016-0196-7. J Nanobiotechnology. 2016. PMID: 27465605 Free PMC article.
• The future of human DNA vaccines.
  Li L, Saade F, Petrovsky N. Li L, et al. J Biotechnol. 2012 Dec 31;162(2-3):171-82. doi: 10.1016/j.jbiotec.2012.08.012. Epub 2012 Sep 7. J Biotechnol. 2012. PMID: 22981627 Free PMC article. Review.
• Graphical representation and mathematical characterization of protein sequences and applications to viral proteins.
  Ghosh A, Nandy A. Ghosh A, et al. Adv Protein Chem Struct Biol. 2011;83:1-42. doi: 10.1016/B978-0-12-381262-9.00001-X. Adv Protein Chem Struct Biol. 2011. PMID: 21570664 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations

• Miscellaneous

  • NCI CPTAC Assay Portal